论文部分内容阅读
Recent isolation of broadly neutralizing monoclonal antibodies (bnmAbs) against HIV-1 has rejuvenated our hope and effort for the development of HIV-1/AIDS vaccine.However,translating bnmAbs information into immunogen design and ultimately be able to use those immunogens to induce bnmAb-like antibody response in human are the greatest challenge.